Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTRECTINIB vs EPCORITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENTRECTINIB vs EPCORITAMAB: Safety Overview

Metric ENTRECTINIB EPCORITAMAB
Total FAERS Reports 1,491 2,041
Deaths Reported 246 430
Death Rate 16.5% 21.1%
Hospitalizations 316 1,652
Average Patient Age 59.8 yrs 67.5 yrs
% Female Patients 58.1% 47.5%
FDA Approval Date Aug 15, 2019 N/A
Manufacturer Genentech, Inc. Genmab US, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A